| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $181K | +3.3% |
| SG&A Expense | $70K | -79.8% |
| Operating Income | -$513K | +31.1% |
| Interest Expense | $43K | +102.9% |
| Pre-tax Income | -$567K | +3.1% |
| Income Tax | $0 | — |
| Net Income | -$567K | +3.1% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Current Assets | $100K | -5.7% |
| Total Assets | $100K | -5.7% |
| Current Liabilities | $3.2M | +20.2% |
| Total Liabilities | $3.2M | +20.2% |
| Stockholders' Equity | -$3.1M | -21.2% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$125K | -13.3% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $100K | +7.5% |